Dr Daniel Goldberg, a pioneer in Laser eye surgery and the director of vision correction at the Atlantic Laser Vision Center was awarded ‘Top Doctor” by Castle Connolly Medical.

Castle Connolly Medical Ltd. is a healthcare research and information company founded in 1991. Their goal is to help guide consumers to America’s top doctors and top hospitals using a detailed survey and comprehensive research

Dr Goldberg’s award recognizes him as one of the best doctors in the field of Ophthalmology. Dr Goldberg is credited as one of the first laser eye surgeons to help bring advanced technologies in the field to the United States. Dr. Daniel Goldberg has a rare dual certification from both the Council for Refractive Surgery Quality Assurance (an independent, nonprofit, patient and consumer health organization that evaluates and verifies the quality of the surgeries provided by select refractive surgeons in the United States), and the ABES( American Board of Eye Surgeons ). Nationwide, there are less than 10 LASIK surgeons with dual certification by ABES and CRSQA.

Dr Goldberg was a member of the elite team of doctors who performed clinical trials of LASIK in its early stages. This research led to FDA approval of LASIK. In 2000, at the ASCRS(American Society of Cataract and Refractive Surgeons) national meeting, the first large scale study of LASIK monovision was presented by Goldberg and the published paper appeared in 2001 in the Journal of Cataract and Refractive Surgery. Further research by Goldberg resulted in another large study of LASIK monovision which was published in 2003—this work compared results in far-sighted eyes as well as near-sighted eyes. Based on this research, Goldberg made presentations at national meetings on “Succeeding with LASIK Monovision” and taught courses at the ASCRS meetings on “Surgical correction of Presbyopia.”

In April of 2008, Dr Goldberg was recognized at the inaugural training session for Custom Vue Monovision in Chicago for helping to set the stage for the FDA approval of LASIK monovision.

For more information, visit www.goldberg4lasik.com

LASIK eye surgery is one of the most commonly performed elective surgical procedures in the United States.  With approximately 1.4 million LASIK procedures performed each year, the demand for the procedure has continued to increase.  With that demand comes the need for continued advancements in technologies and equipment in laser vision correction.

Dr. Daniel B Goldberg, Director of Refractive/LASIK Surgery, at The Atlantic Laser Vision Center in Little Silver, NJ  has a long-standing commitment to providing the most advanced technology for all his procedures, and that’s a great asset for potential patients.

The Atlantic Laser Center uses the WaveScan Wavefront analyzer which can more accurately customize Excimer laser treatments.  The WaveScan is estimated to be 25X more accurate than measurements with lenses used in eyeglasses and contact lenses.  Dr. Goldberg states that “the results with customized LASIK have elevated the quality of results, and the results with all-laser Femtosecond laser flaps have elevated both the safety and the quality of results.  We have reached a new level in LASIK.”

Dr. Goldberg helped introduce the use of IntraLase® in New Jersey, knowing it represented an extraordinary leap in refractive surgery. IntraLase® is more precise and safe than a microkeratome, or mechanical blade, in the critical first step of LASIK: creating the corneal flap. Replacing the microkeratome with IntraLase® gives LASIK patients a critical added safety factor.  Now, New Jersey LASIK patients have a safer, more precise alternative to the tiny handheld blade used by most to create the flap.

In addition, the Atlantic Laser Center in Little Silver has continued to upgrade its lasers to provide the latest technologies and the best results.  The facility is the first in New Jersey, and one of the first in the US to combine the Intralase Femtosecond all-laser, no-blade flap with the VISX customized Excimer laser platform.  “Our system now has been revised to integrate all of the new technology,” Goldberg says, “we have continued to bring the very best LASIK technologies to New Jersey which benefits our patients with safer and more accurate results.”  The the latest addition of iris registration theVISX S4 registers the treatment more accurately while delivering more precise customized treatment.

The new technologies qualify the facility as one of only a few centers in New Jersey certified to perform iLASIK.  iLASIK is a proprietary procedure performed on American Medical Optic’s (AMO) best equipment-WaveScan, Intralase, and VISX S4 with iris registration and FDA approved custom monovision.  In 2007 the FDA approved customVue monovision, which is part of the iLASIK platform.  Now all of these technologies-WaveScan, Intralase, VISX S4, and CustomVue monovision have been combined by AMO as iLASIK.  As further evidence of the advantages of this technology, the US Air Force, US Navy, and NASA have chosen the iLASIK platform for their pilots and astronauts.  All of these major advancements will result in safer, more exact laser vision correction results for patients at the Atlantic Laser Center in Little Silver, New Jersey.

For more information, please visit www.lasiksurgery-nj.com

About Dr. Goldberg

Dr. Daniel B Goldberg is a comprehensive refractive surgeon – both a pioneer of LASIK surgery in the U.S. and an accomplished corneal and cataract surgeon.   Dr. Goldberg specializes in comprehensive refractive surgery including LASIK eye surgery and refractive intraocular lens and cataract surgery.  With 30 years of experience in refractive surgery, Dr. Goldberg has performed over 10,000 LASIK eye surgery procedures. Based in Monmouth County, New Jersey, Dr. Goldberg has performed LASIK on patients worldwide and was a member of the elite team of doctors who performed clinical trials of LASIK in its early stages. This research led to FDA approval of LASIK.

There are two organizations which provide certification of LASIK surgeons based on surgical skills and results.  Dr. Daniel Goldberg has a rare dual certification from both the Council for Refractive Surgery Quality Assurance (an independent, nonprofit, patient and consumer health organization that evaluates and verifies the quality of the surgeries provided by select refractive surgeons in the United States), and the ABES(American Board of Eye Surgeons).

The ABES(American Board of Eye Surgeons) promotes the highest possible quality ophthalmologic surgical care.  The ABES certification programs include a process through which a surgeon’s actual surgical skills and judgment are tested and observed by his or her peers.  The ABES tests surgical skills in cataract/intraocular lens surgery as well as LASIK and corneal transplantation.  In 1989, Dr Goldberg was the first eye surgeon in New Jersey to have surgical skills in cataract and intraocular lens surgery certified by ABES.  In 2002 he became one of 2 New Jersey LASIK surgeons to have surgical skills certified in LASIK by ABES.

The other organization to certify LASIK surgeons is the non-profit, patient advocacy CRSQA(Council of Refractive Surgery Quality Assurance).  According to CRSQA, certification is an important indication of the quality of a LASIK doctor, and once certified, results are re-evaluated every three months.  There are fewer than 250 doctors nationwide who have attained and maintain certification by CRSQA.

Nationwide, there are less than 10 LASIK surgeons with dual certification by ABES and CRSQA.  Daniel B.Goldberg MD of the Atlantic Laser Vision Center in Little Silver, NJ is the only NJ eye surgeon and one of only 10 eye surgeons nationwide to have dual certification in LASIK based on review of actual surgical skills and results.

Information on Dr. Daniel Goldberg and his practice is available at http://www.goldberg4lasik.com/

Laser Vision Correction, including LASIK and related procedures such as PRK(photorefractive keratectomy), and ASA(advanced surface ablation) have become the most common refractive surgical procedures with over 1.4 million procedures yearly in the US.  Steady advances in technology have contributed to the quality of results, and the safety of the procedure.

Consider the added safety of a femtosecond laser flap(e.g. Intralase all-laser LASIK or iLASIK) compared to blade LASIK with a microkeratome.  According to Dr. Goldberg, who is one of the first NJ eye surgeons to pioneer LASIK in New Jersey, and who also was one of the first to bring Intralase all-laser LASIK to the east coast:  “Safety is my top priority.  Using the best technology is part of the process, but proper patient selection and meticulous surgical technique is the key to success.”

The FDA scrutinizes and approves the safety of laser eye surgery technology.  Dr. Goldberg advises patients to seek the best combination of technology and an experienced surgical team.  He feels that surgical certification of actual surgical results is an important protection for patients:  “It demonstrates that the surgeon has the confidence to have their surgical skills and results evaluated.  I have always supported the principle that surgical skills and results should be evaluated objectively.”

Board certification by the American Board of Ophthalmology (ABO) is knowledge based but does not measure surgical skills.  Goldberg says:  “As a result, I continue to voluntarily validate my results thru ABES and CRSQA.  It is part of my service to patients to demonstrate our qualifications, and to protect their vision.”
About Dr. Goldberg

Abour Dr. Daniel Goldberg

Dr. Daniel B Goldberg is a comprehensive refractive surgeon – both a pioneer of LASIK surgery in the U.S. and an accomplished corneal and cataract surgeon.   Dr. Goldberg specializes in comprehensive refractive surgery including LASIK eye surgery and refractive intraocular lens and cataract surgery.  Based in Monmouth County, New Jersey, Dr. Goldberg has performed LASIK on patients worldwide and was a member of the elite team of doctors who performed clinical trials of LASIK in its early stages. This research led to FDA approval of LASIK.